← Leaderboards
Amylou Constance Dueck
Mayo Clinic Arizona
$7,961,797
Attributed
$9,440,534
Total exposure
5
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2015–25$2M$1.5M$1M$500K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$9,440,534 · 5
By mechanism
P01$3,314,979 · 2
U01$2,957,475 · 1
P30$2,520,413 · 1
P50$647,667 · 1
Top collaborators
- Ethan M. Basch6 shared
Most similar at Mayo Clinic Arizona
Same institution · by research overlap
- David William Scott$1,492,205
- Mitesh Borad$4,321,070
Others in their field
Top investigators on “Reporting”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Jeffrey P Krischer · University Of South Florida$564,567,727
- Tracy L Nolen · Research Triangle Institute$474,487,152
- Bambra Strokes · Ppd Development Lp$461,655,950
- Mitchell J Malone · Texas A&M Research Foundation$344,583,004
- Gary D Acton · University Of California-Davis$320,373,312
Research focus
ReportingClinical TrialsCollaborationsResearch PersonnelClinical Trials DesignStatistical Data InterpretationPatient Outcomes AssessmentsMonitorFundingData ManagementResearch DesignTranslational ResearchData CollectionData AnalysesProgramsEnsureResearch Project GrantsMemberBiometryData SetStatistical ModelsMultidimensional DataQuality ControlGrant
Grant awards (25)
Core C: Biostatistics and Data Management Core$436,008
P01 · FY2025 · CA · contact PI
Core C: Biostatistics and Data Management Core$414,208
P01 · FY2024 · CA · contact PI
Biostatistics Shared Resource$43,668
P30 · FY2024 · CA · contact PI
Biostatistics Shared Resource$484,269
P30 · FY2023 · CA · contact PI
Core C: Biostatistics and Data Management Core$453,259
P01 · FY2023 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$269,200
U01 · FY2023 · CA
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$554,283
U01 · FY2022 · CA
Biostatistics Shared Resource$484,393
P30 · FY2022 · CA · contact PI
Core C: Biostatistics and Data Management$377,497
P01 · FY2022 · CA · contact PI
Biostatistics Shared Resource$484,269
P30 · FY2021 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$469,493
U01 · FY2021 · CA
Core C: Biostatistics and Data Management$385,201
P01 · FY2021 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$530,934
U01 · FY2020 · CA
Biostatistics Shared Resource$486,711
P30 · FY2020 · CA · contact PI
Core C: Biostatistics and Data Management$414,623
P01 · FY2020 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$537,655
U01 · FY2019 · CA
Biostatistics Shared Resource$537,103
P30 · FY2019 · CA · contact PI
Core C: Biostatistics and Data Management$402,185
P01 · FY2019 · CA · contact PI
Biostatistics and Bioinformatics$112,415
P50 · FY2019 · CA · contact PI
Analyzing and Interpreting PRO-CTCAE with CTCAE and Other Clinical Data to Characterize Drug Tolerability$595,910
U01 · FY2018 · CA
Core C: Biostatistics and Data Management$431,998
P01 · FY2018 · CA · contact PI
Biostatistics and Bioinformatics$158,888
P50 · FY2018 · CA · contact PI
Biostatistics and Bioinformatics$125,905
P50 · FY2017 · CA · contact PI
Biostatistics and Bioinformatics$124,445
P50 · FY2016 · CA · contact PI
Biostatistics and Bioinformatics$126,014
P50 · FY2015 · CA · contact PI